RSC Advances
Paper
glasses, face shields, leather coat, ear plugs and earthening MHz): d 10.49 (s, 1H), 10.40 (s, 1H), 9.15 (s, 1H), 7.23 (s, 1H), 6.93 (d,
equipment and person) should be taken during the synthesis, J ¼ 8.20 Hz, 1H), 6.77 (d, J ¼ 8.20 Hz, 1H), 1.46 (s, 9H); 13C NMR
test and measurement processes, especially when these (DMSO-d6, 125 MHz): d 155.00, 152.39, 132.59, 129.24, 124.24,
compounds are prepared on a larger scale.
110.42, 107.63, 99.21, 78.10, 27.66; anal. calcd for C12H15N3O3: C,
57.82; H, 6.07; N, 16.86; found: C, 57.70; H, 6.16; N, 16.80%; MS
(ESI) m/z: 250.02 (M + H).
Materials and instruments
2-Chloro-N-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-
The starting materials used in the present study were of AR acetamide (4). To a stirred solution of 5-amino-1H-benzo[d]
grade and purchased from the trade without further purica- imidazol-2(3H)-one (1) (1.0 g, 6.7 mmol) in acetonitrile (30 mL),
tion. Melting point was measured on a X-4 melting point was added dropwise chloroacetyl chloride (1.5 mL) at room
apparatus and was uncorrected. 1H NMR (500 MHz) and 13C temperature, and maintained for 40 min. The reaction mixture
NMR (125 MHz) were recorded on Bruker Avance Spectrometer was then ltered, washed with water, and dried to give 2-chloro-
(TMS as an internal standard). Chemical shis (d) are reported N-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)acetamide (4) as
in part per million (ppm). The coupling constants (J) are a pale pink solid (1.36 g, 90%), m.p. >300 ꢁC; IR: 3289, 2997,
1
reported in hertz (Hz). High-resolution mass spectra were 1729, 1675, 1653, 1539, 1505, 1473, 1203, 1027, 845 cmꢀ1; H
recorded on a Finnigan TSQ Quantum ultra AM mass spec- NMR (DMSO-d6, 500 MHz): d 10.60 (s, 1H), 10.55 (s, 1H), 10.18
trometer. Elemental analysis was carried out on Perkin-Elmer (s, 1H), 7.45 (s, 1H), 7.02 (d, J ¼ 8.30 Hz, 1H), 6.86 (d, J ¼ 8.30 Hz,
instrument.
1H), 4.22 (s, 2H); 13C NMR (DMSO-d6, 125 MHz): d 163.57,
Theoretical calculations were carried out by using the 154.97, 131.54, 129.18, 125.55, 111.51, 107.81, 100.28, 43.10;
Gaussian 09 program suite.17 The geometry optimization of the anal. calcd for C9H8ClN3O2: C, 47.91; H, 3.57; N, 18.62; found: C,
molecular structure and frequency analyses were carried out by 47.85; H, 3.48; N, 18.68%; MS (ESI) m/z: 225.96 227.97 ¼ 3 : 1 (M
using the B3LYP functional with the 6-31G** basis set. The + H).
optimized structure was characterized to be true local energy
N-(1,3-Diacetyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-
minima on the potential-energy surface without imaginary acetamide (5). 5-Amino-1H-benzo[d]imidazol-2(3H)-one (1) (6.0 g,
frequencies. The designed isodesmic reactions for the predic- 40.3 mmol) was dissolved in 60 mL of acetic anhydride, the
tion of (DH0f gas) are discussed in the ESI.†18,19
reaction mixture was heated to 120 ꢁC and maintained three
5-Amino-1,3,6-trinitro-1H-benzo[d]imidazol-2(3H)-one (2). hours at this temperature, then the precipitate was cooled to 0 ꢁC,
(a) From 1: 5-amino-1H-benzo[d]imidazol-2(3H)-one (1) (3.0 g, ltered off, thoroughly washed with dichloromethane, then
20.1 mmol) was added slowly to a solution of fuming nitric acid water, and dried to give N-(1,3-diacetyl-2-oxo-2,3-dihydro-1H-
(6 mL) and acetic anhydride (50 mL) which was stirred at the ice benzo[d]imidazol-5-yl)acetamide (5) as a white solid (10.5 g,
ꢁ
bath. The reaction mixture was kept stirring for 30 min, and 95%), m.p. 248–250 C (dec.); IR: 1762, 1703, 1485, 1431, 1360,
poured into crushed ice, and then ltered, washed with water 1313, 1243, 1179, 1011, 823 cmꢀ1; 1H NMR (DMSO-d6, 500 MHz):
and dried to give 5-amino-1,3,6-trinitro-1H-benzo[d]imidazol- d 10.10 (s, 1H), 8.43 (s, 1H), 8.00 (d, J ¼ 8.85 Hz, 1H), 7.56 (d, J ¼
2(3H)-one (2) as a yellow solid (0.6 g, 11%); IR: 3073, 2246, 1732, 8.85 Hz, 1H), 2.64 (s, 3H), 2.63 (s, 3H), 2.03 (s, 3H); 13C NMR
1603, 1560, 1510, 1440, 1370, 1324, 1238, 1210, 1116, 983, 824 (DMSO-d6, 125 MHz): d 169.72, 169.46, 167.71, 150.39, 135.91,
cmꢀ1; 1H NMR (DMSO-d6, 500 MHz): d 12.59 (s, 2H), 8.55 (s, 1H), 126.18, 121.41, 114.67, 113.97, 105.47, 25.45, 25.27, 23.45; anal.
8.14 (s, 1H); 13C NMR (DMSO-d6, 125 MHz): d 154.59, 141.55, calcd for C13H13N3O4: C, 56.72; H, 4.76; N, 15.27; found: C, 56.65;
138.60, 132.65, 112.70, 107.45, 98.65; anal. calcd for C7H4N6O7: H, 4.71; N, 15.35%; MS (ESI) m/z: 297.95 (M + Na).
C, 29.59; H, 1.42; N, 29.58; found: C, 29.51; H, 1.35; N, 29.50%.
N-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)acetamide (6).
(b) From 11: 1-acetyl-5-amino-6-nitro-1H-benzo[d]imidazol- 5-Amino-1H-benzo[d]imidazol-2(3H)-one (1) (5.0 g, 33.56 mmol)
2(3H)-one (11) (0.20 g, 0.8 mmol) was added very slowly to a was dissolved in 5ꢁ0 mL of acetic anhydride, the reaction mixture
solution of 20% N2O5/HNO3 (1 g) and
2 mL of tri- was heated to 40 C and maintained four hours at this temper-
uoromethanesulfonic acid (TFMSAA) which was stirred at the ature, then the precipitate was cooled to 0 ꢁC, ltered off, washed
ice bath. The reaction mixture was maintained stirring for 20 with dichloromethane, and then water, and dried to give N-(2-
min, and poured into crushed ice, then ltered, washed with oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)acetamide (6) as
water and dried to give 5-amino-1,3,6-trinitro-1H-benzo[d]imi- white solid (6.3 g, 98%), m.p. >300 ꢁC; IR: 2989, 1719, 1651, 1621,
dazol-2(3H)-one (2) as a yellow solid (0.18 g, 75%), whose 1H 1539, 1501, 1364, 1273, 1254, 1203, 1157, 1029, 885 cmꢀ1 1H
NMR was identied with an authentic sample. NMR (DMSO-d6, 500 MHz): d 10.51 (s, 1H), 10.45 (s, 1H), 9.77 (s,
a
;
tert-Butyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-ylcarbamate 1H), 7.45 (s, 1H), 6.83 (d, J ¼ 7.9 Hz, 1H), 6.81 (d, J ¼ 7.9 Hz, 1H),
(3). To a stirred solution of 5-amino-1H-benzo[d]imidazol-2(3H)-one 2.00 (s, 3H); 13C NMR (DMSO-d6, 125 MHz): d 167.18, 154.98,
(1) (1.0 g, 6.7 mmol) in methanol (30 mL), dibutyldicarbonate (2.5 132.52, 129.08, 124.86, 111.06, 107.65, 100.05, 23.40; anal. calcd
mL) was added dropwise at room temperature. The reaction for C9H9N3O2: C, 56.54; H, 4.74; N, 21.98; found: C, 56.48; H, 4.67;
mixture was evaporated aer 30 min, and crystallized in methanol N, 22.05%; MS (ESI) m/z: 214.02 (M + Na).
to
give
tert-butyl-2-oxo-2,3-dihydro-1H-benzo-[d]imidazol-5-
2-Chloro-N-(4,6-dinitro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-
ylcarbamate (3) as a pale pink solid (1.9 g, 96%), m.p. 245–247 ꢁC 5-yl)acetamide (7). 2-Chloro-N-(2-oxo-2,3-dihydro-1H-benzo[d]
(dec.); IR: 3344, 3125, 2984, 1694, 1643, 1512, 1474, 1388, 1291, imidazol-5-yl)acetamide (4) (3.0 g, 13.3 mmol) was added slowly
1235, 1211, 1163, 1053, 1024, 852 cmꢀ1; H NMR (DMSO-d6, 500 to a solution of fuming nitric acid (4 mL) and concentrated sulfuric
1
42216 | RSC Adv., 2014, 4, 42215–42219
This journal is © The Royal Society of Chemistry 2014